Linda Liau, M.D., Ph.D. - Publications

Brain Research Institute, Neurological Surgery University of California, Los Angeles, Los Angeles, CA 
Anaplastic astrocytoma, ependymoma, ganglioma, GBM

178 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Dovek L, Nguyen NT, Ozer BH, Li N, Elashoff RM, Green RM, Liau L, Nghiemphu PL, Cloughesy TF, Lai A. Correlation of commercially available quantitative (O-6-methylguanine-DNA methyltransferase) promoter methylation scores and GBM patient survival. Neuro-Oncology Practice. 6: 194-202. PMID 31386024 DOI: 10.1093/nop/npy028  0.52
2019 Liu LY, Ji MS, Nguyen NT, Chow FE, Molaie DM, Pianka ST, Green RM, Liau LM, Ellingson BM, Nghiemphu PL, Cloughesy TF, Lai A. Patterns of long-term survivorship following bevacizumab treatment for recurrent glioma: a case series. Cns Oncology. CNS35. PMID 31293169 DOI: 10.2217/cns-2019-0007  0.52
2019 McKinney A, Lindberg OR, Engler JR, Chen KY, Kumar A, Gong H, Lu KV, Simonds EF, Cloughesy TF, Liau LM, Prados M, Bollen AW, Berger MS, Shieh JTC, James CD, et al. Mechanisms of resistance to EGFR inhibition reveal metabolic vulnerabilities in human GBM. Molecular Cancer Therapeutics. PMID 31270152 DOI: 10.1158/1535-7163.MCT-18-1330  0.52
2019 Lim-Fat MJ, Bi WL, Lo J, Lee EQ, Ahluwalia MS, Batchelor TT, Chang SM, Chiocca EA, Chukwueke U, Cloughesy TF, Colman H, Deangelis LM, Galanis E, Gilbert MR, De Groot JF, ... ... Liau LM, et al. Letter: When Less is More: Dexamethasone Dosing for Brain Tumors. Neurosurgery. PMID 31215634 DOI: 10.1093/neuros/nyz186  0.52
2019 Yao J, Chakhoyan A, Nathanson DA, Yong WH, Salamon N, Raymond C, Mareninov S, Lai A, Nghiemphu PL, Prins RM, Pope WB, Everson RG, Liau LM, Cloughesy TF, Ellingson BM. Metabolic characterization of human IDH mutant and wild type gliomas using simultaneous pH- and oxygen-sensitive molecular MRI. Neuro-Oncology. PMID 31066901 DOI: 10.1093/neuonc/noz078  0.68
2019 Liu F, Cox CD, Chowdhury R, Dovek L, Nguyen H, Li T, Li S, Ozer B, Chou A, Nguyen N, Wei B, Antonios J, Soto H, Kornblum H, Liau L, et al. SPINT2 is hypermethylated in both IDH1 mutated and wild-type glioblastomas, and exerts tumor suppression via reduction of c-Met activation. Journal of Neuro-Oncology. PMID 30838489 DOI: 10.1007/s11060-019-03126-x  0.44
2019 Chakhoyan A, Yao J, Leu K, Pope WB, Salamon N, Yong W, Lai A, Nghiemphu PL, Everson RG, Prins RM, Liau LM, Nathanson DA, Cloughesy TF, Ellingson BM. Validation of vessel size imaging (VSI) in high-grade human gliomas using magnetic resonance imaging, image-guided biopsies, and quantitative immunohistochemistry. Scientific Reports. 9: 2846. PMID 30808879 DOI: 10.1038/s41598-018-37564-w  0.68
2019 Yao J, Tan CHP, Schlossman J, Chakhoyan A, Raymond C, Pope WB, Salamon N, Lai A, Ji M, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. pH-weighted amine chemical exchange saturation transfer echoplanar imaging (CEST-EPI) as a potential early biomarker for bevacizumab failure in recurrent glioblastoma. Journal of Neuro-Oncology. PMID 30806888 DOI: 10.1007/s11060-019-03132-z  0.52
2019 Cloughesy TF, Mochizuki AY, Orpilla JR, Hugo W, Lee AH, Davidson TB, Wang AC, Ellingson BM, Rytlewski JA, Sanders CM, Kawaguchi ES, Du L, Li G, Yong WH, Gaffey SC, ... ... Liau LM, et al. Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma. Nature Medicine. PMID 30742122 DOI: 10.1038/s41591-018-0337-7  0.52
2018 Davidson TB, Lee AH, Hsu M, Sedighim S, Orpilla J, Treger J, Mastall M, Roesch S, Rapp C, Galvez M, Mochizuki AY, Antonios JP, Garcia AJ, Kotecha N, Bayless NL, ... ... Liau LM, et al. Expression of PD-1 by T cells in malignant glioma patients reflects exhaustion and activation. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30498094 DOI: 10.1158/1078-0432.CCR-18-1176  0.68
2018 Yao J, Ruan D, Raymond C, Liau LM, Salamon N, Pope WB, Nghiemphu PL, Lai A, Cloughesy TF, Ellingson BM. Improving B Correction for pH-Weighted Amine Proton Chemical Exchange Saturation Transfer (CEST) Imaging by Use of k-Means Clustering and Lorentzian Estimation. Tomography (Ann Arbor, Mich.). 4: 123-137. PMID 30320212 DOI: 10.18383/j.tom.2018.00017  0.52
2018 Cavalli FMG, Hübner JM, Sharma T, Luu B, Sill M, Zapotocky M, Mack SC, Witt H, Lin T, Shih DJH, Ho B, Santi M, Emery L, Hukin J, Dunham C, ... ... Liau LM, et al. Heterogeneity within the PF-EPN-B ependymoma subgroup. Acta Neuropathologica. PMID 30019219 DOI: 10.1007/s00401-018-1888-x  0.36
2018 Everson RG, Antonios JP, Liau LM. Cell-Based Immunotherapy of Gliomas. Progress in Neurological Surgery. 32: 90-100. PMID 29990977 DOI: 10.1159/000469683  0.68
2018 Liau LM, Ashkan K, Tran DD, Campian JL, Trusheim JE, Cobbs CS, Heth JA, Salacz M, Taylor S, D'Andre SD, Iwamoto FM, Dropcho EJ, Moshel YA, Walter KA, Pillainayagam CP, et al. Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma. Journal of Translational Medicine. 16: 179. PMID 29958537 DOI: 10.1186/s12967-018-1552-1  0.52
2018 Chakhoyan A, Woodworth DC, Harris RJ, Lai A, Nghiemphu PL, Liau LM, Pope WB, Cloughesy TF, Ellingson BM. Mono-exponential, diffusion kurtosis and stretched exponential diffusion MR imaging response to chemoradiation in newly diagnosed glioblastoma. Journal of Neuro-Oncology. PMID 29855771 DOI: 10.1007/s11060-018-2910-9  0.52
2018 Liau LM, Ashkan K, Tran DD, Campian JL, Trusheim JE, Cobbs CS, Heth JA, Salacz M, Taylor S, D'Andre SD, Iwamoto FM, Dropcho EJ, Moshel YA, Walter KA, Pillainayagam CP, et al. First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma. Journal of Translational Medicine. 16: 142. PMID 29843811 DOI: 10.1186/s12967-018-1507-6  0.52
2018 Kong XT, Nguyen NT, Choi YJ, Zhang G, Nguyen HN, Filka E, Green S, Yong WH, Liau LM, Green RM, Kaprealian T, Pope WB, Nghiemphu PL, Cloughesy T, Lassman A, et al. Phase 2 Study of Bortezomib Combined With Temozolomide and Regional Radiation Therapy for Upfront Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Safety and Efficacy Assessment. International Journal of Radiation Oncology, Biology, Physics. 100: 1195-1203. PMID 29722661 DOI: 10.1016/j.ijrobp.2018.01.001  0.44
2018 Garrett M, Sperry J, Braas D, Yan W, Le TM, Mottahedeh J, Ludwig K, Eskin A, Qin Y, Levy R, Breunig JJ, Pajonk F, Graeber TG, Radu CG, Christofk H, ... ... Liau LM, et al. Metabolic characterization of isocitrate dehydrogenase (IDH) mutant and IDH wildtype gliomaspheres uncovers cell type-specific vulnerabilities. Cancer & Metabolism. 6: 4. PMID 29692895 DOI: 10.1186/s40170-018-0177-4  0.44
2018 Harris RJ, Yao J, Chakhoyan A, Raymond C, Leu K, Liau LM, Nghiemphu PL, Lai A, Salamon N, Pope WB, Cloughesy TF, Ellingson BM. Simultaneous pH-sensitive and oxygen-sensitive MRI of human gliomas at 3 T using multi-echo amine proton chemical exchange saturation transfer spin-and-gradient echo echo-planar imaging (CEST-SAGE-EPI). Magnetic Resonance in Medicine. PMID 29626359 DOI: 10.1002/mrm.27204  0.52
2018 Li T, Cox CD, Ozer B, Nguyen NT, Nguyen HN, Lai TJ, Li S, Liu F, Kornblum HI, Liau LM, Nghiemphu PL, Cloughesy TF, Lai A. D-2-Hydroxyglutarate is Necessary and Sufficient for Isocitrate Dehydrogenase 1 Mutant-induced MIR148A Promoter Methylation. Molecular Cancer Research : McR. PMID 29545476 DOI: 10.1158/1541-7786.MCR-17-0367  0.52
2017 Chung LK, Pelargos PE, Chan AM, Demos JV, Lagman C, Sheppard JP, Nguyen T, Chang YL, Hojat SA, Prins RM, Liau LM, Nghiemphu L, Lai A, Cloughesy TF, Yong WH, et al. Tissue microarray analysis for epithelial membrane protein-2 as a novel biomarker for gliomas. Brain Tumor Pathology. PMID 28887715 DOI: 10.1007/s10014-017-0300-1  0.52
2017 Antonios JP, Soto H, Everson RG, Moughon DL, Wang AC, Orpilla J, Radu C, Ellingson BM, Lee JT, Cloughesy T, Phelps ME, Czernin J, Liau LM, Prins RM. Detection of immune responses after immunotherapy in glioblastoma using PET and MRI. Proceedings of the National Academy of Sciences of the United States of America. PMID 28874539 DOI: 10.1073/pnas.1706689114  0.68
2017 Movassaghi M, Shabihkhani M, Hojat SA, Williams RR, Chung LK, Im K, Lucey GM, Wei B, Mareninov S, Wang MW, Ng DW, Tashjian RS, Magaki S, Perez-Rosendahl M, Yang I, ... ... Liau LM, et al. Early experience with formalin-fixed paraffin-embedded (FFPE) based commercial clinical genomic profiling of gliomas-robust and informative with caveats. Experimental and Molecular Pathology. PMID 28663030 DOI: 10.1016/j.yexmp.2017.06.006  0.52
2017 Leu K, Ott GA, Lai A, Nghiemphu PL, Pope WB, Yong WH, Liau LM, Cloughesy TF, Ellingson BM. Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II-III diffuse gliomas. Journal of Neuro-Oncology. PMID 28547590 DOI: 10.1007/s11060-017-2506-9  0.52
2017 Shabihkhani M, Telesca D, Movassaghi M, Naeini YB, Naeini KM, Hojat SA, Gupta D, Lucey GM, Ontiveros M, Wang MW, Hanna LS, Sanchez DE, Mareninov S, Khanlou N, Vinters HV, ... ... Liau LM, et al. Incidence, survival, pathology, and genetics of adult Latino Americans with glioblastoma. Journal of Neuro-Oncology. PMID 28161760 DOI: 10.1007/s11060-017-2377-0  0.52
2017 Antonios JP, Soto H, Everson RG, Moughon D, Orpilla JR, Shin NP, Sedighim S, Treger J, Odesa S, Tucker A, Yong WH, Li G, Cloughesy TF, Liau LM, Prins RM. Immunosuppressive tumor-infiltrating myeloid cells mediate adaptive immune resistance via a PD-1/PD-L1 mechanism in glioblastoma. Neuro-Oncology. PMID 28115578 DOI: 10.1093/neuonc/now287  0.68
2016 Abdaljaleel M, Mazumder R, Patel CB, Im K, Pope W, Liau LM, Vinters HV, Yong WH. Multiple calcifying pseudoneoplasms of the neuraxis (MCAPNON): Distinct entity, CAPNON variant, or old neurocysticercosis? Neuropathology : Official Journal of the Japanese Society of Neuropathology. PMID 27862397 DOI: 10.1111/neup.12349  0.44
2016 Harris RJ, Cloughesy TF, Liau LM, Nghiemphu PL, Lai A, Pope WB, Ellingson BM. Simulation, phantom validation, and clinical evaluation of fast pH-weighted molecular imaging using amine chemical exchange saturation transfer echo planar imaging (CEST-EPI) in glioma at 3 T. Nmr in Biomedicine. PMID 27717216 DOI: 10.1002/nbm.3611  0.52
2016 Nguyen HN, Lie A, Li T, Chowdhury R, Liu F, Ozer B, Wei B, Green RM, Ellingson BM, Wang HJ, Elashoff R, Liau LM, Yong WH, Nghiemphu PL, Cloughesy T, et al. Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy. Neuro-Oncology. PMID 27571882 DOI: 10.1093/neuonc/now189  0.44
2016 Antonios JP, Soto H, Everson RG, Orpilla J, Moughon D, Shin N, Sedighim S, Yong WH, Li G, Cloughesy TF, Liau LM, Prins RM. PD-1 blockade enhances the vaccination-induced immune response in glioma. Jci Insight. 1. PMID 27453950 DOI: 10.1172/jci.insight.87059  0.68
2016 Ramaswamy V, Hielscher T, Mack SC, Lassaletta A, Lin T, Pajtler KW, Jones DT, Luu B, Cavalli FM, Aldape K, Remke M, Mynarek M, Rutkowski S, Gururangan S, McLendon RE, ... ... Liau LM, et al. Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 27269943 DOI: 10.1200/JCO.2015.65.7825  0.68
2016 Cloughesy TF, Landolfi J, Hogan DJ, Bloomfield S, Carter B, Chen CC, Elder JB, Kalkanis SN, Kesari S, Lai A, Lee IY, Liau LM, Mikkelsen T, Nghiemphu PL, Piccioni D, et al. Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma. Science Translational Medicine. 8: 341ra75. PMID 27252174 DOI: 10.1126/scitranslmed.aad9784  0.68
2016 Laks DR, Crisman TJ, Shih MY, Mottahedeh J, Gao F, Sperry J, Garrett MC, Yong WH, Cloughesy TF, Liau LM, Lai A, Coppola G, Kornblum HI. Large-scale assessment of the gliomasphere model system. Neuro-Oncology. PMID 27116978 DOI: 10.1093/neuonc/now045  0.68
2016 Ellingson BM, Nguyen HN, Lai A, Nechifor RE, Zaw O, Pope WB, Yong WH, Nghiemphu PL, Liau LM, Cloughesy TF. Contrast-enhancing tumor growth dynamics of preoperative, treatment-naive human glioblastoma. Cancer. PMID 26998740 DOI: 10.1002/cncr.29957  0.68
2016 Hsu M, Sedighim S, Wang T, Antonios JP, Everson RG, Tucker AM, Du L, Emerson R, Yusko E, Sanders C, Robins H, Yong WH, Davidson TB, Li G, Liau LM, et al. TCR sequencing can identify and track glioma-infiltrating T cells after DC vaccination. Cancer Immunology Research. PMID 26968205 DOI: 10.1158/2326-6066.CIR-15-0240  0.44
2015 Tso JL, Yang S, Menjivar JC, Yamada K, Zhang Y, Hong I, Bui Y, Stream A, McBride WH, Liau LM, Nelson SF, Cloughesy TF, Yong WH, Lai A, Tso CL. Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide. Molecular Cancer. 14: 189. PMID 26546412 DOI: 10.1186/s12943-015-0459-1  0.68
2015 Reardon DA, Gilbert MR, Wick W, Liau L. Immunotherapy for neuro-oncology: the critical rationale for combinatorial therapy. Neuro-Oncology. 17: vii32-vii40. PMID 26516225 DOI: 10.1093/neuonc/nov178  0.36
2015 Yong WH, Shabihkhani M, Telesca D, Yang S, Tso JL, Menjivar JC, Wei B, Lucey GM, Mareninov S, Chen Z, Liau LM, Lai A, Nelson SF, Cloughesy TF, Tso CL. Ribosomal Proteins RPS11 and RPS20, Two Stress-Response Markers of Glioblastoma Stem Cells, Are Novel Predictors of Poor Prognosis in Glioblastoma Patients. Plos One. 10: e0141334. PMID 26506620 DOI: 10.1371/journal.pone.0141334  0.68
2015 Everson RG, Antonios JP, Lisiero DN, Soto H, Scharnweber R, Garrett MC, Yong WH, Li N, Li G, Kruse CA, Liau LM, Prins RM. Efficacy of systemic adoptive transfer immunotherapy targeting NY-ESO-1 for glioblastoma. Neuro-Oncology. PMID 26330563 DOI: 10.1093/neuonc/nov153  0.68
2015 Heaney AP, Sumerel B, Rajalingam R, Bergsneider M, Yong WH, Liau LM. HLA Markers DQ8 and DR53 Are Associated With Lymphocytic Hypophysitis and May Aid in Differential Diagnosis. The Journal of Clinical Endocrinology and Metabolism. 100: 4092-7. PMID 26317559 DOI: 10.1210/jc.2015-2702  0.68
2015 Harris RJ, Cloughesy TF, Liau LM, Prins RM, Antonios JP, Li D, Yong WH, Pope WB, Lai A, Nghiemphu PL, Ellingson BM. pH-weighted molecular imaging of gliomas using amine chemical exchange saturation transfer MRI. Neuro-Oncology. PMID 26113557 DOI: 10.1093/neuonc/nov106  0.68
2015 Antonios JP, Everson RG, Liau LM. Dendritic cell immunotherapy for brain tumors. Journal of Neuro-Oncology. 123: 425-32. PMID 26037466 DOI: 10.1007/s11060-015-1830-1  0.68
2015 Harris RJ, Cloughesy TF, Hardy AJ, Liau LM, Pope WB, Nghiemphu PL, Lai A, Ellingson BM. MRI perfusion measurements calculated using advanced deconvolution techniques predict survival in recurrent glioblastoma treated with bevacizumab. Journal of Neuro-Oncology. 122: 497-505. PMID 25773062 DOI: 10.1007/s11060-015-1755-8  0.68
2015 Erickson KL, Hickey MJ, Kato Y, Malone CC, Owens GC, Prins RM, Liau LM, Kasahara N, Kruse CA. Radial mobility and cytotoxic function of retroviral replicating vector transduced, non-adherent alloresponsive T lymphocytes. Journal of Visualized Experiments : Jove. PMID 25741775 DOI: 10.3791/52416  0.68
2015 Karavaeva E, Harris RJ, Leu K, Shabihkhani M, Yong WH, Pope WB, Lai A, Nghiemphu PL, Liau LM, Chen W, Czernin J, Cloughesy TF, Ellingson BM. Relationship Between [18F]FDOPA PET Uptake, Apparent Diffusion Coefficient (ADC), and Proliferation Rate in Recurrent Malignant Gliomas. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 17: 434-42. PMID 25465392 DOI: 10.1007/s11307-014-0807-3  0.68
2015 Lim M, Liau LM. Introduction: brain tumor immunotherapy Journal of Neuro-Oncology. DOI: 10.1007/s11060-015-1848-4  0.68
2014 Zhukova N, Ramaswamy V, Remke M, Martin DC, Castelo-Branco P, Zhang CH, Fraser M, Tse K, Poon R, Shih DJ, Baskin B, Ray PN, Bouffet E, Dirks P, von Bueren AO, ... ... Liau LM, et al. WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastoma. Acta Neuropathologica Communications. 2: 174. PMID 25539912 DOI: 10.1186/s40478-014-0174-y  0.68
2014 Li S, Chowdhury R, Liu F, Chou AP, Li T, Mody RR, Lou JJ, Chen W, Reiss J, Soto H, Prins R, Liau LM, Mischel PS, Nghiemphu PL, Yong WH, et al. Tumor-suppressive miR148a is silenced by CpG island hypermethylation in IDH1-mutant gliomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 5808-22. PMID 25224277 DOI: 10.1158/1078-0432.CCR-14-0234  0.68
2014 Lisiero DN, Soto H, Everson RG, Liau LM, Prins RM. The histone deacetylase inhibitor, LBH589, promotes the systemic cytokine and effector responses of adoptively transferred CD8+ T cells. Journal For Immunotherapy of Cancer. 2: 8. PMID 25054063 DOI: 10.1186/2051-1426-2-8  0.68
2014 Everson RG, Jin RM, Wang X, Safaee M, Scharnweber R, Lisiero DN, Soto H, Liau LM, Prins RM. Cytokine responsiveness of CD8(+) T cells is a reproducible biomarker for the clinical efficacy of dendritic cell vaccination in glioblastoma patients. Journal For Immunotherapy of Cancer. 2: 10. PMID 24883189 DOI: 10.1186/2051-1426-2-10  0.68
2014 Piccioni DE, Selfridge J, Mody RR, Chowdhury R, Li S, Lalezari S, Wawrzynski J, Quan J, Zurayk M, Chou AP, Sanchez DE, Liau LM, Ellingson BM, Pope WB, Nghiemphu PL, et al. Deferred use of bevacizumab for recurrent glioblastoma is not associated with diminished efficacy. Neuro-Oncology. 16: 815-22. PMID 24627236 DOI: 10.1093/neuonc/nou028  0.68
2014 Shih DJ, Northcott PA, Remke M, Korshunov A, Ramaswamy V, Kool M, Luu B, Yao Y, Wang X, Dubuc AM, Garzia L, Peacock J, Mack SC, Wu X, Rolider A, ... ... Liau LM, et al. Cytogenetic prognostication within medulloblastoma subgroups. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 886-96. PMID 24493713 DOI: 10.1200/JCO.2013.50.9539  0.68
2014 Avliyakulov NK, Rajavel KS, Le KM, Guo L, Mirsadraei L, Yong WH, Liau LM, Li S, Lai A, Nghiemphu PL, Cloughesy TF, Linetsky M, Haykinson MJ, Pope WB. C-terminally truncated form of αB-crystallin is associated with IDH1 R132H mutation in anaplastic astrocytoma. Journal of Neuro-Oncology. 117: 53-65. PMID 24473683 DOI: 10.1007/s11060-014-1371-z  0.68
2014 Woodworth DC, Pope WB, Liau LM, Kim HJ, Lai A, Nghiemphu PL, Cloughesy TF, Ellingson BM. Nonlinear distortion correction of diffusion MR images improves quantitative DTI measurements in glioblastoma. Journal of Neuro-Oncology. 116: 551-8. PMID 24318915 DOI: 10.1007/s11060-013-1320-2  0.68
2014 Harris RJ, Bookheimer SY, Cloughesy TF, Kim HJ, Pope WB, Lai A, Nghiemphu PL, Liau LM, Ellingson BM. Altered functional connectivity of the default mode network in diffuse gliomas measured with pseudo-resting state fMRI. Journal of Neuro-Oncology. 116: 373-9. PMID 24234804 DOI: 10.1007/s11060-013-1304-2  0.68
2013 Leu K, Pope WB, Cloughesy TF, Lai A, Nghiemphu PL, Chen W, Liau LM, Ellingson BM. Imaging biomarkers for antiangiogenic therapy in malignant gliomas. Cns Oncology. 2: 33-47. PMID 24570837 DOI: 10.2217/cns.12.29  0.68
2013 Ye F, Zhang Y, Liu Y, Yamada K, Tso JL, Menjivar JC, Tian JY, Yong WH, Schaue D, Mischel PS, Cloughesy TF, Nelson SF, Liau LM, McBride W, Tso CL. Protective properties of radio-chemoresistant glioblastoma stem cell clones are associated with metabolic adaptation to reduced glucose dependence. Plos One. 8: e80397. PMID 24260384 DOI: 10.1371/journal.pone.0080397  0.68
2013 Remke M, Ramaswamy V, Peacock J, Shih DJ, Koelsche C, Northcott PA, Hill N, Cavalli FM, Kool M, Wang X, Mack SC, Barszczyk M, Morrissy AS, Wu X, Agnihotri S, ... ... Liau LM, et al. TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma. Acta Neuropathologica. 126: 917-29. PMID 24174164 DOI: 10.1007/s00401-013-1198-2  0.68
2013 Chen WW, Balaj L, Liau LM, Samuels ML, Kotsopoulos SK, Maguire CA, Loguidice L, Soto H, Garrett M, Zhu LD, Sivaraman S, Chen C, Wong ET, Carter BS, Hochberg FH, et al. BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular Vesicles. Molecular Therapy. Nucleic Acids. 2: e109. PMID 23881452 DOI: 10.1038/mtna.2013.28  0.68
2013 Zhukova N, Ramaswamy V, Remke M, Pfaff E, Shih DJ, Martin DC, Castelo-Branco P, Baskin B, Ray PN, Bouffet E, von Bueren AO, Jones DT, Northcott PA, Kool M, Sturm D, ... ... Liau LM, et al. Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 2927-35. PMID 23835706 DOI: 10.1200/JCO.2012.48.5052  0.68
2013 Papour A, Taylor Z, Sherman A, Sanchez D, Lucey G, Liau L, Stafsudd O, Yong W, Grundfest W. Optical imaging for brain tissue characterization using relative fluorescence lifetime imaging. Journal of Biomedical Optics. 18: 60504. PMID 23760460 DOI: 10.1117/1.JBO.18.6.060504  0.68
2013 Lasky JL, Panosyan EH, Plant A, Davidson T, Yong WH, Prins RM, Liau LM, Moore TB. Autologous tumor lysate-pulsed dendritic cell immunotherapy for pediatric patients with newly diagnosed or recurrent high-grade gliomas. Anticancer Research. 33: 2047-56. PMID 23645755  0.68
2013 Mareninov S, De Jesus J, Sanchez DE, Kay AB, Wilson RW, Babic I, Chen W, Telesca D, Lou JJ, Mirsadraei L, Gardner TP, Khanlou N, Vinters HV, Shafa BB, Lai A, ... Liau LM, et al. Lyophilized brain tumor specimens can be used for histologic, nucleic acid, and protein analyses after 1 year of room temperature storage. Journal of Neuro-Oncology. 113: 365-73. PMID 23640138 DOI: 10.1007/s11060-013-1135-1  0.68
2013 Williams KJ, Argus JP, Zhu Y, Wilks MQ, Marbois BN, York AG, Kidani Y, Pourzia AL, Akhavan D, Lisiero DN, Komisopoulou E, Henkin AH, Soto H, Chamberlain BT, Vergnes L, ... ... Liau LM, et al. An essential requirement for the SCAP/SREBP signaling axis to protect cancer cells from lipotoxicity. Cancer Research. 73: 2850-62. PMID 23440422 DOI: 10.1158/0008-5472.CAN-13-0382-T  0.68
2013 Prins RM, Wang X, Soto H, Young E, Lisiero DN, Fong B, Everson R, Yong WH, Lai A, Li G, Cloughesy TF, Liau LM. Comparison of glioma-associated antigen peptide-loaded versus autologous tumor lysate-loaded dendritic cell vaccination in malignant glioma patients. Journal of Immunotherapy (Hagerstown, Md. : 1997). 36: 152-7. PMID 23377664 DOI: 10.1097/CJI.0b013e3182811ae4  0.68
2013 Morris LG, Kaufman AM, Gong Y, Ramaswami D, Walsh LA, Turcan ?, Eng S, Kannan K, Zou Y, Peng L, Banuchi VE, Paty P, Zeng Z, Vakiani E, Solit D, ... ... Liau L, et al. Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation. Nature Genetics. 45: 253-61. PMID 23354438 DOI: 10.1038/ng.2538  0.68
2013 Lalezari S, Chou AP, Tran A, Solis OE, Khanlou N, Chen W, Li S, Carrillo JA, Chowdhury R, Selfridge J, Sanchez DE, Wilson RW, Zurayk M, Lalezari J, Lou JJ, ... ... Liau LM, et al. Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcome. Neuro-Oncology. 15: 370-81. PMID 23328811 DOI: 10.1093/neuonc/nos308  0.68
2013 Ellingson BM, Cloughesy TF, Lai A, Nghiemphu PL, Liau LM, Pope WB. Quantitative probabilistic functional diffusion mapping in newly diagnosed glioblastoma treated with radiochemotherapy. Neuro-Oncology. 15: 382-90. PMID 23275575 DOI: 10.1093/neuonc/nos314  0.68
2013 Li S, Chou AP, Chen W, Chen R, Deng Y, Phillips HS, Selfridge J, Zurayk M, Lou JJ, Everson RG, Wu KC, Faull KF, Cloughesy T, Liau LM, Lai A. Overexpression of isocitrate dehydrogenase mutant proteins renders glioma cells more sensitive to radiation. Neuro-Oncology. 15: 57-68. PMID 23115158 DOI: 10.1093/neuonc/nos261  0.68
2013 Ellingson BM, Lai A, Harris RJ, Selfridge JM, Yong WH, Das K, Pope WB, Nghiemphu PL, Vinters HV, Liau LM, Mischel PS, Cloughesy TF. Probabilistic radiographic atlas of glioblastoma phenotypes. Ajnr. American Journal of Neuroradiology. 34: 533-40. PMID 22997168 DOI: 10.3174/ajnr.A3253  0.68
2012 Yang I, Jian Y, Garcia H, Choy W, Nagasawa DT, Spasic M, Trang A, Soto H, Ericcson K, Lisiero D, Hickey M, Kruse C, Prins RM, Rome L, Liau LM. 198 An Antigen Vault Nanoparticle Vaccine Can Effectively Stimulate Dendritic Cells and Activate a Specific T cell Immune Response. Neurosurgery. 71: E576-E577. PMID 28175807 DOI: 10.1227/01.neu.0000417788.76126.66  0.52
2012 Lazovic J, Soto H, Piccioni D, Lou JR, Li S, Mirsadraei L, Yong W, Prins R, Liau LM, Ellingson BM, Cloughesy TF, Lai A, Pope WB. Detection of 2-hydroxyglutaric acid in vivo by proton magnetic resonance spectroscopy in U87 glioma cells overexpressing isocitrate dehydrogenase-1 mutation. Neuro-Oncology. 14: 1465-72. PMID 23090985 DOI: 10.1093/neuonc/nos258  0.68
2012 Chou AP, Chowdhury R, Li S, Chen W, Kim AJ, Piccioni DE, Selfridge JM, Mody RR, Chang S, Lalezari S, Lin J, Sanchez DE, Wilson RW, Garrett MC, Harry B, ... ... Liau LM, et al. Identification of retinol binding protein 1 promoter hypermethylation in isocitrate dehydrogenase 1 and 2 mutant gliomas. Journal of the National Cancer Institute. 104: 1458-69. PMID 22945948 DOI: 10.1093/jnci/djs357  0.68
2012 Garrett MC, Pouratian N, Liau LM. Use of language mapping to aid in resection of gliomas in eloquent brain regions. Neurosurgery Clinics of North America. 23: 497-506. PMID 22748661 DOI: 10.1016/  0.68
2012 Kim W, Liau LM. IDH mutations in human glioma. Neurosurgery Clinics of North America. 23: 471-80. PMID 22748659 DOI: 10.1016/  0.68
2012 Yang J, Nagasawa DT, Spasic M, Amolis M, Choy W, Garcia HM, Prins RM, Liau LM, Yang I. Endogenous vaults and bioengineered vault nanoparticles for treatment of glioblastomas: implications for future targeted therapies. Neurosurgery Clinics of North America. 23: 451-8. PMID 22748657 DOI: 10.1016/  0.68
2012 Vivanco I, Robins HI, Rohle D, Campos C, Grommes C, Nghiemphu PL, Kubek S, Oldrini B, Chheda MG, Yannuzzi N, Tao H, Zhu S, Iwanami A, Kuga D, Dang J, ... ... Liau LM, et al. Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors. Cancer Discovery. 2: 458-71. PMID 22588883 DOI: 10.1158/2159-8290.CD-11-0284  0.68
2012 Fong B, Jin R, Wang X, Safaee M, Lisiero DN, Yang I, Li G, Liau LM, Prins RM. Monitoring of regulatory T cell frequencies and expression of CTLA-4 on T cells, before and after DC vaccination, can predict survival in GBM patients. Plos One. 7: e32614. PMID 22485134 DOI: 10.1371/journal.pone.0032614  0.68
2012 Hickey MJ, Malone CC, Erickson KE, Gomez GG, Young EL, Liau LM, Prins RM, Kruse CA. Implementing preclinical study findings to protocol design: translational studies with alloreactive CTL for gliomas. American Journal of Translational Research. 4: 114-26. PMID 22347526  0.32
2012 Ellingson BM, Cloughesy TF, Zaw T, Lai A, Nghiemphu PL, Harris R, Lalezari S, Wagle N, Naeini KM, Carrillo J, Liau LM, Pope WB. Functional diffusion maps (fDMs) evaluated before and after radiochemotherapy predict progression-free and overall survival in newly diagnosed glioblastoma. Neuro-Oncology. 14: 333-43. PMID 22270220 DOI: 10.1093/neuonc/nor220  0.68
2012 Pope WB, Prins RM, Albert Thomas M, Nagarajan R, Yen KE, Bittinger MA, Salamon N, Chou AP, Yong WH, Soto H, Wilson N, Driggers E, Jang HG, Su SM, Schenkein DP, ... ... Liau LM, et al. Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy. Journal of Neuro-Oncology. 107: 197-205. PMID 22015945 DOI: 10.1007/s11060-011-0737-8  0.68
2012 Yang I, Choy W, Kim W, Alakandy L, Voth B, Prins RM, Liau LM. Active immunotherapy in glioma: Focus on cell-based approaches Drugs of the Future. 37: 19-31. DOI: 10.1358/dof.2012.37.1.1703571  0.68
2012 Hickey MJ, Malone CC, Erickson KE, Gomez GG, Young EL, Liau LM, Prins RM, Kruse CA. Implementing preclinical study findings to protocol design: Translational studies with alloreactive CTL for gliomas American Journal of Translational Research. 4: 114-126.  0.68
2011 Yamada K, Tso J, Ye F, Choe J, Liu Y, Liau LM, Tso CL. Essential gene pathways for glioblastoma stem cells: clinical implications for prevention of tumor recurrence. Cancers. 3: 1975-95. PMID 24212792 DOI: 10.3390/cancers3021975  0.68
2011 Konkankit VV, Kim W, Koya RC, Eskin A, Dam MA, Nelson S, Ribas A, Liau LM, Prins RM. Decitabine immunosensitizes human gliomas to NY-ESO-1 specific T lymphocyte targeting through the Fas/Fas ligand pathway. Journal of Translational Medicine. 9: 192. PMID 22060015 DOI: 10.1186/1479-5876-9-192  0.68
2011 Lai A, Kharbanda S, Pope WB, Tran A, Solis OE, Peale F, Forrest WF, Pujara K, Carrillo JA, Pandita A, Ellingson BM, Bowers CW, Soriano RH, Schmidt NO, Mohan S, ... ... Liau LM, et al. Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 4482-90. PMID 22025148 DOI: 10.1200/JCO.2010.33.8715  0.68
2011 Liu Y, Ye F, Yamada K, Tso JL, Zhang Y, Nguyen DH, Dong Q, Soto H, Choe J, Dembo A, Wheeler H, Eskin A, Schmid I, Yong WH, Mischel PS, ... ... Liau LM, et al. Autocrine endothelin-3/endothelin receptor B signaling maintains cellular and molecular properties of glioblastoma stem cells. Molecular Cancer Research : McR. 9: 1668-85. PMID 22013079 DOI: 10.1158/1541-7786.MCR-10-0563  0.68
2011 Ellingson BM, Cloughesy TF, Lai A, Nghiemphu PL, Liau LM, Pope WB. High order diffusion tensor imaging in human glioblastoma. Academic Radiology. 18: 947-54. PMID 21536466 DOI: 10.1016/j.acra.2011.02.020  0.68
2011 Lisiero DN, Soto H, Liau LM, Prins RM. Enhanced sensitivity to IL-2 signaling regulates the clinical responsiveness of IL-12-primed CD8(+) T cells in a melanoma model. Journal of Immunology (Baltimore, Md. : 1950). 186: 5068-77. PMID 21430221 DOI: 10.4049/jimmunol.1003317  0.68
2011 Lai A, Tran A, Nghiemphu PL, Pope WB, Solis OE, Selch M, Filka E, Yong WH, Mischel PS, Liau LM, Phuphanich S, Black K, Peak S, Green RM, Spier CE, et al. Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 142-8. PMID 21135282 DOI: 10.1200/JCO.2010.30.2729  0.68
2011 Prins RM, Soto H, Konkankit V, Odesa SK, Eskin A, Yong WH, Nelson SF, Liau LM. Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 1603-15. PMID 21135147 DOI: 10.1158/1078-0432.CCR-10-2563  0.68
2011 Sun S, Wang Q, Giang A, Cheng C, Soo C, Wang CY, Liau LM, Chiu R. Knockdown of CypA inhibits interleukin-8 (IL-8) and IL-8-mediated proliferation and tumor growth of glioblastoma cells through down-regulated NF-κB. Journal of Neuro-Oncology. 101: 1-14. PMID 20454998 DOI: 10.1007/s11060-010-0220-y  0.68
2010 Cohen JR, Resnick DZ, Niewiadomski P, Dong H, Liau LM, Waschek JA. Pituitary adenylyl cyclase activating polypeptide inhibits gli1 gene expression and proliferation in primary medulloblastoma derived tumorsphere cultures. Bmc Cancer. 10: 676. PMID 21143927 DOI: 10.1186/1471-2407-10-676  0.68
2010 Hickey MJ, Malone CC, Erickson KL, Jadus MR, Prins RM, Liau LM, Kruse CA. Cellular and vaccine therapeutic approaches for gliomas. Journal of Translational Medicine. 8: 100. PMID 20946667 DOI: 10.1186/1479-5876-8-100  0.68
2010 Yang I, Liau LM. American Association for Cancer Research Genetics and Biology of Brain Cancers 2009, December 13-15, 2009, San Diego, CA. Journal of Neuro-Oncology. 99: 297-306. PMID 20714783 DOI: 10.1007/s11060-010-0332-4  0.68
2010 Zada G, Chen TC. A novel method for administering intrathecal chemotherapy in patients with leptomeningeal metastases and shunted hydrocephalus: case report. Neurosurgery. 67: onsE306-7; discussio. PMID 20679917 DOI: 10.1227/01.NEU.0000383138.78632.BA  0.68
2010 Sun J, Masterman-Smith MD, Graham NA, Jiao J, Mottahedeh J, Laks DR, Ohashi M, DeJesus J, Kamei K, Lee KB, Wang H, Yu ZT, Lu YT, Hou S, Li K, ... ... Liau LM, et al. A microfluidic platform for systems pathology: multiparameter single-cell signaling measurements of clinical brain tumor specimens. Cancer Research. 70: 6128-38. PMID 20631065 DOI: 10.1158/0008-5472.CAN-10-0076  0.68
2010 Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, Fantin VR, Jang HG, Jin S, Keenan MC, Marks KM, Prins RM, Ward PS, Yen KE, Liau LM, et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature. 465: 966. PMID 20559394 DOI: 10.1038/nature09132  0.68
2010 DiLuna ML, Levy GH, Sood S, Duncan CC. Primary myxopapillary ependymoma of the medulla: case report. Neurosurgery. 66: E1208-9; discussion . PMID 20495393 DOI: 10.1227/01.NEU.0000369513.84063.A6  0.68
2010 Vivanco I, Rohle D, Versele M, Iwanami A, Kuga D, Oldrini B, Tanaka K, Dang J, Kubek S, Palaskas N, Hsueh T, Evans M, Mulholland D, Wolle D, Rajasekaran S, ... ... Liau LM, et al. The phosphatase and tensin homolog regulates epidermal growth factor receptor (EGFR) inhibitor response by targeting EGFR for degradation. Proceedings of the National Academy of Sciences of the United States of America. 107: 6459-64. PMID 20308550 DOI: 10.1073/pnas.0911188107  0.68
2010 Lee Y, Liu J, Patel S, Cloughesy T, Lai A, Farooqi H, Seligson D, Dong J, Liau L, Becker D, Mischel P, Shams S, Nelson S. Genomic landscape of meningiomas. Brain Pathology (Zurich, Switzerland). 20: 751-62. PMID 20015288 DOI: 10.1111/j.1750-3639.2009.00356.x  0.68
2010 Veeriah S, Taylor BS, Meng S, Fang F, Yilmaz E, Vivanco I, Janakiraman M, Schultz N, Hanrahan AJ, Pao W, Ladanyi M, Sander C, Heguy A, Holland EC, Paty PB, ... ... Liau L, et al. Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies. Nature Genetics. 42: 77-82. PMID 19946270 DOI: 10.1038/ng.491  0.68
2010 Kim W, Liau LM. Dendritic cell vaccines for brain tumors. Neurosurgery Clinics of North America. 21: 139-57. PMID 19944973 DOI: 10.1016/  0.68
2010 Kappadakunnel M, Eskin A, Dong J, Nelson SF, Mischel PS, Liau LM, Ngheimphu P, Lai A, Cloughesy TF, Goldin J, Pope WB. Stem cell associated gene expression in glioblastoma multiforme: relationship to survival and the subventricular zone. Journal of Neuro-Oncology. 96: 359-67. PMID 19655089 DOI: 10.1007/s11060-009-9983-4  0.68
2010 Liau LM. Comment Neurosurgery. 66: 156-157. DOI: 10.1227/01.NEU.0000363149.58885.2E  0.68
2009 Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, Fantin VR, Jang HG, Jin S, Keenan MC, Marks KM, Prins RM, Ward PS, Yen KE, Liau LM, et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature. 462: 739-44. PMID 19935646 DOI: 10.1038/nature08617  0.68
2009 Shen A, Wang Y, Zhao Y, Zou L, Sun L, Cheng C. Expression of CRM1 in human gliomas and its significance in p27 expression and clinical prognosis. Neurosurgery. 65: 153-9; discussion 15. PMID 19574837 DOI: 10.1227/01.NEU.0000348550.47441.4B  0.68
2009 Balamurali G, du Plessis DG, Wengoy M, Bryan N, Herwadkar A, Richardson PL. Thorotrast-induced primary cerebral angiosarcoma: case report. Neurosurgery. 65: E210-1; discussion E. PMID 19574803 DOI: 10.1227/01.NEU.0000348294.05571.D9  0.68
2009 McGillicuddy LT, Fromm JA, Hollstein PE, Kubek S, Beroukhim R, De Raedt T, Johnson BW, Williams SM, Nghiemphu P, Liau LM, Cloughesy TF, Mischel PS, Parret A, Seiler J, Moldenhauer G, et al. Proteasomal and genetic inactivation of the NF1 tumor suppressor in gliomagenesis. Cancer Cell. 16: 44-54. PMID 19573811 DOI: 10.1016/j.ccr.2009.05.009  0.68
2009 Lu JQ, Scheithauer BW, Sharma P, Scott JN, Parney IF, Hader W, Burger PC, Clark AW. Multifocal complex glioneuronal tumor in an elderly man: an autopsy study: case report. Neurosurgery. 64: E1193-5; discussion . PMID 19487863 DOI: 10.1227/01.NEU.0000345640.40566.48  0.68
2009 Veeriah S, Brennan C, Meng S, Singh B, Fagin JA, Solit DB, Paty PB, Rohle D, Vivanco I, Chmielecki J, Pao W, Ladanyi M, Gerald WL, Liau L, Cloughesy TC, et al. The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers. Proceedings of the National Academy of Sciences of the United States of America. 106: 9435-40. PMID 19478061 DOI: 10.1073/pnas.0900571106  0.68
2009 Liu Q, Nguyen DH, Dong Q, Shitaku P, Chung K, Liu OY, Tso JL, Liu JY, Konkankit V, Cloughesy TF, Mischel PS, Lane TF, Liau LM, Nelson SF, Tso CL. Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors. Journal of Neuro-Oncology. 94: 1-19. PMID 19468690 DOI: 10.1007/s11060-009-9919-z  0.68
2009 Laks DR, Masterman-Smith M, Visnyei K, Angenieux B, Orozco NM, Foran I, Yong WH, Vinters HV, Liau LM, Lazareff JA, Mischel PS, Cloughesy TF, Horvath S, Kornblum HI. Neurosphere formation is an independent predictor of clinical outcome in malignant glioma. Stem Cells (Dayton, Ohio). 27: 980-7. PMID 19353526 DOI: 10.1002/stem.15  0.68
2009 Nghiemphu PL, Liu W, Lee Y, Than T, Graham C, Lai A, Green RM, Pope WB, Liau LM, Mischel PS, Nelson SF, Elashoff R, Cloughesy TF. Bevacizumab and chemotherapy for recurrent glioblastoma: a single-institution experience. Neurology. 72: 1217-22. PMID 19349600 DOI: 10.1212/01.wnl.0000345668.03039.90  0.68
2009 Chang EF, Clark A, Jensen RL, Bernstein M, Guha A, Carrabba G, Mukhopadhyay D, Kim W, Liau LM, Chang SM, Smith JS, Berger MS, McDermott MW. Multiinstitutional validation of the University of California at San Francisco Low-Grade Glioma Prognostic Scoring System. Clinical article. Journal of Neurosurgery. 111: 203-10. PMID 19267536 DOI: 10.3171/2009.2.JNS081101  0.68
2009 Du J, Bernasconi P, Clauser KR, Mani DR, Finn SP, Beroukhim R, Burns M, Julian B, Peng XP, Hieronymus H, Maglathlin RL, Lewis TA, Liau LM, Nghiemphu P, Mellinghoff IK, et al. Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy. Nature Biotechnology. 27: 77-83. PMID 19098899 DOI: 10.1038/nbt.1513  0.68
2009 Liau LM. Direct intratumoral chemotherapy with carboplatin and epinephrine in a recurrent cervical chordoma: Case report - Commentary Neurosurgery. 65: E630. DOI: 10.1227/01.NEU.0000350864.78326.14  0.68
2009 Liau LM. Anatomic compression caused by high-volume convection-enhanced delivery to the brain: Commentary Neurosurgery. 65: 586. DOI: 10.1227/01.NEU.0000350229.77462.2F  0.68
2009 Liau LM. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells: Commentary Neurosurgery. 65: 624. DOI: 10.1227/01.NEU.0000350227.61132.A7  0.68
2009 Liau LM. Adjuvant treatment with locally delivered oncogel delays the onset of paresis after surgical resection of experimental spinal column metastasis: Commentary Neurosurgery. 65: 200. DOI: 10.1227/01.NEU.0000345948.54008.82  0.68
2009 Liau LM. Human leukocyte antigen frequency in human high-grade gliomas: A case-control study in sicily - Commentary Neurosurgery. 64: 1089. DOI: 10.1227/01.NEU.0000345946.35786.92  0.68
2009 Liau LM. Antitumor treatment using interleukin-12-secreting marrow stromal cells in an invasive glioma model: Commentary Neurosurgery. 64: 1146-1147. DOI: 10.1227/01.NEU.0000345646.85472.EA  0.68
2009 Liau LM. Comments Neurosurgery. 64: 835. DOI: 10.1227/01.NEU.0000343525.89321.C5  0.68
2008 Lee Y, Scheck AC, Cloughesy TF, Lai A, Dong J, Farooqi HK, Liau LM, Horvath S, Mischel PS, Nelson SF. Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age. Bmc Medical Genomics. 1: 52. PMID 18940004 DOI: 10.1186/1755-8794-1-52  0.52
2008 Stevenson CB, Ehtesham M, McMillan KM, Valadez JG, Edgeworth ML, Price RR, Abel TW, Mapara KY, Thompson RC. CXCR4 expression is elevated in glioblastoma multiforme and correlates with an increase in intensity and extent of peritumoral T2-weighted magnetic resonance imaging signal abnormalities. Neurosurgery. 63: 560-9; discussion 56. PMID 18812968 DOI: 10.1227/01.NEU.0000324896.26088.EF  0.68
2008 Crowley RW, Sherman JH, Le BH, Jane JA. Intramedullary spinal cord metastasis from bladder carcinoma: case report. Neurosurgery. 63: E611-2; discussion E. PMID 18812942 DOI: 10.1227/01.NEU.0000324898.69073.E1  0.68
2008 Pope WB, Chen JH, Dong J, Carlson MR, Perlina A, Cloughesy TF, Liau LM, Mischel PS, Nghiemphu P, Lai A, Nelson SF. Relationship between gene expression and enhancement in glioblastoma multiforme: exploratory DNA microarray analysis. Radiology. 249: 268-77. PMID 18796682 DOI: 10.1148/radiol.2491072000  0.68
2008 Prins RM, Cloughesy TF, Liau LM. Cytomegalovirus immunity after vaccination with autologous glioblastoma lysate. The New England Journal of Medicine. 359: 539-41. PMID 18669440 DOI: 10.1056/NEJMc0804818  0.68
2008 Lai A, Filka E, McGibbon B, Nghiemphu PL, Graham C, Yong WH, Mischel P, Liau LM, Bergsneider M, Pope W, Selch M, Cloughesy T. Phase II pilot study of bevacizumab in combination with temozolomide and regional radiation therapy for up-front treatment of patients with newly diagnosed glioblastoma multiforme: interim analysis of safety and tolerability. International Journal of Radiation Oncology, Biology, Physics. 71: 1372-80. PMID 18355978 DOI: 10.1016/j.ijrobp.2007.11.068  0.68
2008 Prins RM, Shu CJ, Radu CG, Vo DD, Khan-Farooqi H, Soto H, Yang MY, Lin MS, Shelly S, Witte ON, Ribas A, Liau LM. Anti-tumor activity and trafficking of self, tumor-specific T cells against tumors located in the brain. Cancer Immunology, Immunotherapy : Cii. 57: 1279-89. PMID 18253732 DOI: 10.1007/s00262-008-0461-1  0.68
2008 Cloughesy TF, Yoshimoto K, Nghiemphu P, Brown K, Dang J, Zhu S, Hsueh T, Chen Y, Wang W, Youngkin D, Liau L, Martin N, Becker D, Bergsneider M, Lai A, et al. Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma. Plos Medicine. 5: e8. PMID 18215105 DOI: 10.1371/journal.pmed.0050008  0.68
2008 Lelievre V, Seksenyan A, Nobuta H, Yong WH, Chhith S, Niewiadomski P, Cohen JR, Dong H, Flores A, Liau LM, Kornblum HI, Scott MP, Waschek JA. Disruption of the PACAP gene promotes medulloblastoma in ptc1 mutant mice. Developmental Biology. 313: 359-70. PMID 18036580 DOI: 10.1016/j.ydbio.2007.10.031  0.68
2008 Nakano I, Masterman-Smith M, Saigusa K, Paucar AA, Horvath S, Shoemaker L, Watanabe M, Negro A, Bajpai R, Howes A, Lelievre V, Waschek JA, Lazareff JA, Freije WA, Liau LM, et al. Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells. Journal of Neuroscience Research. 86: 48-60. PMID 17722061 DOI: 10.1002/jnr.21471  0.68
2008 Asthagiri AR, Lonser RR. Sequential salvage chemotherapy for recurrent intracranial hemangiopericytoma: Commentary Neurosurgery. 63: 727. DOI: 10.1227/01.NEU.0000325494.69836.51  0.68
2008 Liau LM. Usefulness of intraoperative photodynamic diagnosis using 5-aminolevulinic acid for meningiomas with cranial invasion: Technical case report - Commentary Neurosurgery. 62: ONSE103. DOI: 10.1227/01.neu.0000317378.22820.46  0.68
2008 Liau LM. An account of the life and achievements of Miss Diana Beck, neurosurgeon (1902-1956): Commentary Neurosurgery. 62: 741. DOI: 10.1227/01.neu.0000317324.71483.e5  0.68
2008 Liau LM. Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas: Commentary Neurosurgery. 62: 515. DOI: 10.1227/01.neu.0000316019.28421.95  0.68
2008 Liau LM. Limitations of diffusion-weighted imaging in the diagnosis of postoperative infections: Commentary Neurosurgery. 62: 582. DOI: 10.1227/01.NEU.0000311349.25281.BD  0.68
2008 Liau LM. Targeting the α1 subunit of the sodium pump to combat glioblastoma cells - Commentary Neurosurgery. 62: 221. DOI: 10.1227/01.NEU.0000311080.43024.0E  0.68
2008 Liau LM. Angiogenesis and gliomas: Current issues and development of surrogate markers - Commentary Neurosurgery. 62: 51. DOI: 10.1227/01.NEU.0000311060.65002.4E  0.68
2008 Liau LM. Commentary Surgical Neurology. 70: 266-267. DOI: 10.1016/j.surneu.2007.07.041  0.68
2008 Liau LM, Cavenee WK. Editors' message to the readership Journal of Neuro-Oncology. 86: 1. DOI: 10.1007/s11060-007-9481-5  0.68
2007 Beroukhim R, Getz G, Nghiemphu L, Barretina J, Hsueh T, Linhart D, Vivanco I, Lee JC, Huang JH, Alexander S, Du J, Kau T, Thomas RK, Shah K, Soto H, ... ... Liau L, et al. Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proceedings of the National Academy of Sciences of the United States of America. 104: 20007-12. PMID 18077431 DOI: 10.1073/pnas.0710052104  0.68
2007 Ito M, Wakabayashi T, Natsume A, Hatano H, Fujii M, Yoshida J. Genetically heterogeneous glioblastoma recurring with disappearance of 1p/19q losses: case report. Neurosurgery. 61: E168-9; discussion E. PMID 17621007 DOI: 10.1227/01.neu.0000279739.53425.5c  0.68
2007 Carlson MR, Pope WB, Horvath S, Braunstein JG, Nghiemphu P, Tso CL, Mellinghoff I, Lai A, Liau LM, Mischel PS, Dong J, Nelson SF, Cloughesy TF. Relationship between survival and edema in malignant gliomas: role of vascular endothelial growth factor and neuronal pentraxin 2. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 2592-8. PMID 17473188 DOI: 10.1158/1078-0432.CCR-06-2772  0.68
2007 Thomas RK, Baker AC, Debiasi RM, Winckler W, Laframboise T, Lin WM, Wang M, Feng W, Zander T, MacConaill L, Macconnaill LE, Lee JC, Nicoletti R, Hatton C, Goyette M, ... ... Liau LM, et al. High-throughput oncogene mutation profiling in human cancer. Nature Genetics. 39: 347-51. PMID 17293865 DOI: 10.1038/ng1975  0.68
2007 Liau LM. Intraventricular dysembryoplastic neuroepithelial tumor: Case report - Commentary Neurosurgery. 61: E1333. DOI: 10.1227/01.neu.0000306114.08540.aa  0.68
2007 Liau LM. Effects of drug efflux on convection-enhanced paclitaxel delivery to malignant gliomas: Technical note - Commentary Neurosurgery. 61: E882. DOI: 10.1227/01.NEU.0000298922.77921.F2  0.68
2007 Liau LM. Clinical significance of ABCA2, a possible molecular marker for oligodendrogliomas: Commentary Neurosurgery. 60: 714. DOI: 10.1227/01.NEU.0000255395.15657.06  0.68
2006 Lee JC, Vivanco I, Beroukhim R, Huang JH, Feng WL, DeBiasi RM, Yoshimoto K, King JC, Nghiemphu P, Yuza Y, Xu Q, Greulich H, Thomas RK, Paez JG, Peck TC, ... ... Liau LM, et al. Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain. Plos Medicine. 3: e485. PMID 17177598 DOI: 10.1371/journal.pmed.0030485  0.68
2006 Prins RM, Vo DD, Khan-Farooqi H, Yang MY, Soto H, Economou JS, Liau LM, Ribas A. NK and CD4 cells collaborate to protect against melanoma tumor formation in the brain. Journal of Immunology (Baltimore, Md. : 1950). 177: 8448-55. PMID 17142742  0.68
2006 Horvath S, Zhang B, Carlson M, Lu KV, Zhu S, Felciano RM, Laurance MF, Zhao W, Qi S, Chen Z, Lee Y, Scheck AC, Liau LM, Wu H, Geschwind DH, et al. Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proceedings of the National Academy of Sciences of the United States of America. 103: 17402-7. PMID 17090670 DOI: 10.1073/pnas.0608396103  0.68
2006 Yang MY, Zetler PM, Prins RM, Khan-Farooqi H, Liau LM. Immunotherapy for patients with malignant glioma: from theoretical principles to clinical applications. Expert Review of Neurotherapeutics. 6: 1481-94. PMID 17078788 DOI: 10.1586/14737175.6.10.1481  0.68
2006 Tso CL, Shintaku P, Chen J, Liu Q, Liu J, Chen Z, Yoshimoto K, Mischel PS, Cloughesy TF, Liau LM, Nelson SF. Primary glioblastomas express mesenchymal stem-like properties. Molecular Cancer Research : McR. 4: 607-19. PMID 16966431 DOI: 10.1158/1541-7786.MCR-06-0005  0.68
2006 Lasky JL, Liau LM. Targeting stem cells in brain tumors. Technology in Cancer Research & Treatment. 5: 251-60. PMID 16700621  0.68
2006 Tso CL, Freije WA, Day A, Chen Z, Merriman B, Perlina A, Lee Y, Dia EQ, Yoshimoto K, Mischel PS, Liau LM, Cloughesy TF, Nelson SF. Distinct transcription profiles of primary and secondary glioblastoma subgroups. Cancer Research. 66: 159-67. PMID 16397228 DOI: 10.1158/0008-5472.CAN-05-0077  0.68
2006 Prins RM, Bruhn KW, Craft N, Lin JW, Kim CH, Odesa SK, Miller JF, Liau LM. Central nervous system tumor immunity generated by a recombinant listeria monocytogenes vaccine targeting tyrosinase related protein-2 and real-time imaging of intracranial tumor burden. Neurosurgery. 58: 169-78; discussion 1. PMID 16385341 DOI: 10.1227/01.NEU.0000192367.29047.64  0.68
2006 Prins RM, Craft N, Bruhn KW, Khan-Farooqi H, Koya RC, Stripecke R, Miller JF, Liau LM. The TLR-7 agonist, imiquimod, enhances dendritic cell survival and promotes tumor antigen-specific T cell priming: relation to central nervous system antitumor immunity. Journal of Immunology (Baltimore, Md. : 1950). 176: 157-64. PMID 16365406  0.68
2006 Liau LM. Dendritic cell vaccination in patients with malignant gliomas: Current status and future directions - Commentary Neurosurgery. 59: 999. DOI: 10.1227/01.NEU.0000245595.38957.3E  0.68
2006 Liau LM. Defective receptor expression and dendritic cell differentiation of monocytes in glioblastomas: Commentary Neurosurgery. 59: 909-910. DOI: 10.1227/01.NEU.0000233907.03070.7B  0.68
2005 Bergsneider M, Sehati N, Villablanca P, McArthur DL, Becker DP, Liau LM. Mahaley Clinical Research Award: extent of glioma resection using low-field (0.2 T) versus high-field (1.5 T) intraoperative MRI and image-guided frameless neuronavigation. Clinical Neurosurgery. 52: 389-99. PMID 16626099  0.68
2005 Mellinghoff IK, Wang MY, Vivanco I, Haas-Kogan DA, Zhu S, Dia EQ, Lu KV, Yoshimoto K, Huang JH, Chute DJ, Riggs BL, Horvath S, Liau LM, Cavenee WK, Rao PN, et al. Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. The New England Journal of Medicine. 353: 2012-24. PMID 16282176 DOI: 10.1056/NEJMoa051918  0.68
2005 Boudreau CR, Yang I, Liau LM. Gliomas: advances in molecular analysis and characterization. Surgical Neurology. 64: 286-94; discussion 2. PMID 16229087  0.68
2005 Khan-Farooqi HR, Prins RM, Liau LM. Tumor immunology, immunomics and targeted immunotherapy for central nervous system malignancies. Neurological Research. 27: 692-702. PMID 16197806 DOI: 10.1179/016164105X49490  0.32
2005 Liau LM, Prins RM, Kiertscher SM, Odesa SK, Kremen TJ, Giovannone AJ, Lin JW, Chute DJ, Mischel PS, Cloughesy TF, Roth MD. Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 5515-25. PMID 16061868 DOI: 10.1158/1078-0432.CCR-05-0464  0.68
2005 Craft N, Bruhn KW, Nguyen BD, Prins R, Lin JW, Liau LM, Miller JF. The TLR7 agonist imiquimod enhances the anti-melanoma effects of a recombinant Listeria monocytogenes vaccine. Journal of Immunology (Baltimore, Md. : 1950). 175: 1983-90. PMID 16034143  0.68
2005 Craft N, Bruhn KW, Nguyen BD, Prins R, Liau LM, Collisson EA, De A, Kolodney MS, Gambhir SS, Miller JF. Bioluminescent imaging of melanoma in live mice. The Journal of Investigative Dermatology. 125: 159-65. PMID 15982316 DOI: 10.1111/j.0022-202X.2005.23759.x  0.68
2005 Chen W, Cloughesy T, Kamdar N, Satyamurthy N, Bergsneider M, Liau L, Mischel P, Czernin J, Phelps ME, Silverman DH. Imaging proliferation in brain tumors with 18F-FLT PET: comparison with 18F-FDG. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 46: 945-52. PMID 15937304  0.68
2005 Mehrian Shai R, Reichardt JK, Ya-Hsuan H, Kremen TJ, Liau LM, Cloughesy TF, Mischel PS, Nelson SF. Robustness of gene expression profiling in glioma specimen samplings and derived cell lines. Brain Research. Molecular Brain Research. 136: 99-103. PMID 15893592 DOI: 10.1016/j.molbrainres.2005.01.017  0.68
2004 Boudreau CR, Liau LM. Molecular characterization of brain tumors. Clinical Neurosurgery. 51: 81-90. PMID 15571131  0.68
2004 Freije WA, Castro-Vargas FE, Fang Z, Horvath S, Cloughesy T, Liau LM, Mischel PS, Nelson SF. Gene expression profiling of gliomas strongly predicts survival. Cancer Research. 64: 6503-10. PMID 15374961 DOI: 10.1158/0008-5472.CAN-04-0452  0.68
2004 Prins RM, Liau LM. Cellular immunity and immunotherapy of brain tumors. Frontiers in Bioscience : a Journal and Virtual Library. 9: 3124-36. PMID 15353342  0.32
2004 Yang I, Kremen TJ, Giovannone AJ, Paik E, Odesa SK, Prins RM, Liau LM. Modulation of major histocompatibility complex Class I molecules and major histocompatibility complex-bound immunogenic peptides induced by interferon-alpha and interferon-gamma treatment of human glioblastoma multiforme. Journal of Neurosurgery. 100: 310-9. PMID 15086239 DOI: 10.3171/jns.2004.100.2.0310  0.68
2002 Liau LM, Jensen ER, Kremen TJ, Odesa SK, Sykes SN, Soung MC, Miller JF, Bronstein JM. Tumor immunity within the central nervous system stimulated by recombinant Listeria monocytogenes vaccination. Cancer Research. 62: 2287-93. PMID 11956085  0.68
2000 Liau LM, Black KL, Martin NA, Sykes SN, Bronstein JM, Jouben-Steele L, Mischel PS, Belldegrun A, Cloughesy TF. Treatment of a patient by vaccination with autologous dendritic cells pulsed with allogeneic major histocompatibility complex class I-matched tumor peptides. Case Report. Neurosurgical Focus. 9: e8. PMID 16817691  0.68
2000 Broder H, Anderson A, Odesa SK, Kremen TJ, Liau LM. Recombinant adenovirus-transduced dendritic cell immunization in a murine model of central nervous system tumor. Neurosurgical Focus. 9: e6. PMID 16817689  0.68
2000 Liau LM, Lallone RL, Seitz RS, Buznikov A, Gregg JP, Kornblum HI, Nelson SF, Bronstein JM. Identification of a human glioma-associated growth factor gene, granulin, using differential immuno-absorption. Cancer Research. 60: 1353-60. PMID 10728698  0.68
1999 Liau LM, Black KL, Prins RM, Sykes SN, DiPatre PL, Cloughesy TF, Becker DP, Bronstein JM. Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens. Journal of Neurosurgery. 90: 1115-24. PMID 10350260 DOI: 10.3171/jns.1999.90.6.1115  0.68
Show low-probability matches.